Table 1.
Demographic characteristics of control and SSRI groups
| Variables | Control (n = 40) | Paroxetine (n = 20) | Citalopram (n = 20) | Sertraline (n = 20) | p |
|---|---|---|---|---|---|
| Age (year) | 56.5 ± 4.2 | 55.0 ± 0.6 | 56.9 ± 3.2 | 56.2 ± 2.6 | 0.261a |
| Body Mass Index | 28.8 ± 3.7 | 27.2 ± 4.6 | 28.7 ± 3.2 | 26.3 ± 3.5 | 0.069a |
| Smoking history (current/former users) | 12 (30.0 %) | 8 (40.0 %) | 7 (35.0 %) | 8 (40.0 %) | 0.830b |
| Duration of disease (month) | – | 42 (24–96) | 36 (18–120) | 48 (24–108) | 0.230c |
| Duration of drug use (month) | – | 24 (12–36) | 24 (12–60) | 30 (12–36) | 0.182c |
| Mean drug dose (mg/day) | – | 30 (20–40) | 20 (10–20) | 62.5(50–100) |
aOne-way ANOVA test
bPearson’s chi-square test
cKruskal-Wallis test